New Life Scientific, Inc. (OTCBB: NWLS) today announced that Peter Goodenow has joined the Company as Vice President of Clinical Operations, PharmaTrials International, a subsidiary of New Life Scientific, effective May 22, 2006. Goodenow, previously with Advanced Biologics, Concepts in Pharmaceutical Research, and Scirex, has assumed overall management responsibilities for PharmaTrials’ CRO clinical operations.
